Gene analysis (runt related transcription factor 1) targeted sequence analysis
Medicare pricing data for 34 providers across 5 states
Note: These costs reflect the Medicare physician/supplier component. Hospital facility fees are billed separately and can be 2-5x the physician fee.
💡 What You Should Know
Gene analysis (runt related transcription factor 1) targeted sequence analysis (HCPCS code 81334) is a medical procedure billed to Medicare. The average Medicare-allowed cost is $322.56, but hospitals typically charge $362.50 — a 1.1x markup. Prices vary significantly by state and provider.
🏷️ Typical Out-of-Pocket Cost
Medicare patients typically pay about 20% of the allowed amount as coinsurance. Based on the average allowed cost of $322.56, your out-of-pocket cost would be approximately $64.51. Actual costs depend on your specific plan, deductible, and whether you've met your annual out-of-pocket maximum.
What Hospitals Charge vs. What Medicare Pays
Hospitals charge 1.1x more than what Medicare allows for this procedure. Medicare actually pays $322.56 on average.
Cost by State
Medicare-allowed amounts vary significantly by state
| State | Allowed Cost | Hospital Charge | Providers | Services | vs. National |
|---|---|---|---|---|---|
| New Jersey | $323 | $330 | 2 | 28 | +0.1% |
| Pennsylvania | $323 | $330 | 2 | 32 | +0.1% |
| Florida | $323 | $360 | 21 | 16,513 | +0.0% |
| Texas | $321 | $374 | 3 | 14 | -0.6% |
| Connecticut | $315 | $989 | 2 | 61 | -2.3% |
⚠️ Important: These costs reflect the Medicare physician/supplier component. Hospital facility fees may be billed separately. Total out-of-pocket costs may be higher.
💊 Need post-procedure medications? Check costs on OpenPrescriber